Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
Sean D. McAllister, Liliana Soroceanu, Pierre‐Yves Desprez
Journal of Neuroimmune Pharmacology (2015) Vol. 10, Iss. 2, pp. 255-267
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland, Franjo Grotenhermen
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 139-154
Open Access | Times Cited: 549
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
Targeting autophagy to sensitive glioma to temozolomide treatment
Yuanliang Yan, Zhijie Xu, Shuang Dai, et al.
Journal of Experimental & Clinical Cancer Research (2016) Vol. 35, Iss. 1
Open Access | Times Cited: 270
Plants as sources of natural and recombinant anti-cancer agents
Johannes F. Buyel
Biotechnology Advances (2018) Vol. 36, Iss. 2, pp. 506-520
Closed Access | Times Cited: 188
Cannabinoids in cancer treatment: Therapeutic potential and legislation
Barbara Dariš, Mojca Tancer Verboten, Željko Knez, et al.
Bosnian Journal of Basic Medical Sciences (2018) Vol. 19, Iss. 1, pp. 14-23
Open Access | Times Cited: 176
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An, Steve Peigneur, Louise Antonia Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5064-5064
Open Access | Times Cited: 159
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martı́nez, Amaia Iriondo‐DeHond, Francesca Borrelli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3067-3067
Open Access | Times Cited: 143
The current state and future perspectives of cannabinoids in cancer biology
Paweł Śledziński, Joanna Zeyland, Ryszard Słomski, et al.
Cancer Medicine (2018) Vol. 7, Iss. 3, pp. 765-775
Open Access | Times Cited: 138
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Guy A. Cabral, Thomas J. Rogers, Aron H. Lichtman
Journal of Neuroimmune Pharmacology (2015) Vol. 10, Iss. 2, pp. 193-203
Open Access | Times Cited: 133
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
Integrating Cannabis into Clinical Cancer Care
Donald I. Abrams
Current Oncology (2016) Vol. 23, Iss. 11, pp. 8-14
Open Access | Times Cited: 112
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro
Lara Milián, Manuel Mata, Javier Alcácer, et al.
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0228909-e0228909
Open Access | Times Cited: 92
Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, et al.
Molecules (2020) Vol. 25, Iss. 3, pp. 652-652
Open Access | Times Cited: 83
Extraction of medicinal cannabinoids through supercritical carbon dioxide technologies: A review
Sadia Qamar, Yady J. M. Torres, Harendra S. Parekh, et al.
Journal of Chromatography B (2021) Vol. 1167, pp. 122581-122581
Closed Access | Times Cited: 56
Cannabidiol (CBD) in Cancer Management
Kylie O’Brien
Cancers (2022) Vol. 14, Iss. 4, pp. 885-885
Open Access | Times Cited: 49
Cannabis Use and Head and Neck Cancer
Tyler J. Gallagher, Ryan S. Chung, Matthew E. Lin, et al.
JAMA Otolaryngology–Head & Neck Surgery (2024)
Closed Access | Times Cited: 13
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
Farideh Javid, Roger M. Phillips, S. Afshinjavid, et al.
European Journal of Pharmacology (2016) Vol. 775, pp. 1-14
Open Access | Times Cited: 75
The Use of Medical Marijuana in Cancer
Shauna Birdsall, Timothy C. Birdsall, Lucas A. Tims
Current Oncology Reports (2016) Vol. 18, Iss. 7
Closed Access | Times Cited: 65
The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review
Saneal Rajanahally, Omer Raheem, M. Rogers, et al.
Andrology (2019) Vol. 7, Iss. 2, pp. 139-147
Open Access | Times Cited: 62
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma
Israel López-Valero, Sofía Torres, María Salazar‐Roa, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 275-284
Closed Access | Times Cited: 60
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
Farjana Afrin, Mengna Chi, Andrew L. Eamens, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1033-1033
Open Access | Times Cited: 55
<p>Cannabidiol as a Novel Therapeutic for Immune Modulation</p>
Nadia Peyravian, Sapna K. Deo, Sylvia Daunert, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 131-140
Open Access | Times Cited: 53
Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism
Sarah H. Shrader, Nicholas Mellen, Jun Cai, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells
Uchini S. Kosgodage, Pinar Uysal‐Onganer, Amy MacLatchy, et al.
Translational Oncology (2018) Vol. 12, Iss. 3, pp. 513-522
Open Access | Times Cited: 51
A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age
Michelle Sexton, Carrie Cuttler, Laurie K. Mischley
The Journal of Alternative and Complementary Medicine (2018) Vol. 25, Iss. 3, pp. 326-335
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top